Hemostemix has announced that it has closed the previously released non-brokered convertible debenture in accordance with offering $1,000 principal amount of each debenture.
Отказ от ответственности
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Отказ от ответственности
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.